Human endothelial gelatinases and angiogenesis

被引:246
作者
Nguyen, M [1 ]
Arkell, J [1 ]
Jackson, CJ [1 ]
机构
[1] Royal N Shore Hosp, Sutton Arthrit Res Lab, St Leonards, NSW 2065, Australia
关键词
human endothelial cells; gelatinases; type I collagen matrix; membrane-type matrix metalloproteinase; thrombin;
D O I
10.1016/S1357-2725(01)00007-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelial cell invasion is an essential event during angiogenesis (formation of new blood vessels). The process involves the degradation of the basement membrane and the underlying interstitium. The matrix metalloproteinase (MMP) family is considered to be primarily responsible for matrix degradation. Two members of the family, gelatinase A and B play an important role in angiogenesis. This review outlines recent findings on their regulation in human endothelial cells. Latent gelatinase B is secreted from endothelial cells. This enzyme can also accumulate in the cytosol as an active enzyme, free of TIMP-1. In contrast, latent galatinase A is constitutively secreted from the cells. Unlike other MMPs, gelatinase A activation occurs on the cell membrane and is mediated by MT1-MMP. A number of physiological activators have recently been described. These include thrombin and activated protein C, both of which activate gelatinase A independent of the MT1-MMP pathway. These new findings may lead to therapeutic interventions for the treatment of angiogenic-dependent diseases such as cancer and arthritis. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:960 / 970
页数:11
相关论文
共 71 条
[1]   MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS [J].
AIMES, RT ;
QUIGLEY, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5872-5876
[2]  
ANANDAPTE B, 1997, INVEST OPHTHALMO VIS, V137, P647
[3]  
Belkhiri A, 1997, LAB INVEST, V77, P533
[4]   ROLE OF MATRIX METALLOPROTEINASES IN HUMAN PERIODONTAL-DISEASES [J].
BIRKEDALHANSEN, H .
JOURNAL OF PERIODONTOLOGY, 1993, 64 (05) :474-484
[5]   A HELPING HAND FOR COLLAGENASES - THE HEMOPEXIN-LIKE DOMAIN [J].
BODE, W .
STRUCTURE, 1995, 3 (06) :527-530
[6]   Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity [J].
Brooks, PC ;
Silletti, S ;
von Schalscha, TL ;
Friedlander, M ;
Cheresh, DA .
CELL, 1998, 92 (03) :391-400
[7]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[8]   The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A - A kinetic study [J].
Butler, GS ;
Butler, MJ ;
Atkinson, SJ ;
Will, H ;
Tamura, T ;
van Westrum, SS ;
Crabbe, T ;
Clements, J ;
d'Ortho, MP ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :871-880
[9]   INHIBITION OF OVULATION IN THE PERFUSED RAT OVARY BY THE SYNTHETIC COLLAGENASE INHIBITOR-SC-44463 [J].
BUTLER, TA ;
ZHU, C ;
MUELLER, RA ;
FULLER, GC ;
LEMAIRE, WJ ;
WOESSNER, JF .
BIOLOGY OF REPRODUCTION, 1991, 44 (06) :1183-1188
[10]   Metalloproteinase inhibitors and the prevention of connective tissue breakdown [J].
Cawston, TE .
PHARMACOLOGY & THERAPEUTICS, 1996, 70 (03) :163-182